Century Therapeutics, Inc. (IPSC)

NASDAQ: IPSC · IEX Real-Time Price · USD
8.79
+0.39 (4.64%)
At close: Jul 1, 2022 4:00 PM
8.75
-0.04 (-0.46%)
After-hours: Jul 1, 2022 6:10 PM EDT

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 20212020
Selling, General & Admin
19.249.5
Research & Development
75.6539.68
Other Operating Expenses
04.72
Operating Expenses
94.8853.9
Operating Income
-94.88-53.9
Interest Expense / Income
1.280.38
Other Expense / Income
-0.38-0.7
Pretax Income
-95.78-53.58
Income Tax
0.040
Net Income
-95.82-53.58
Net Income Common
-95.82-53.58
Shares Outstanding (Basic)
327
Shares Outstanding (Diluted)
327
Shares Change
332.95%-
EPS (Basic)
-2.96-7.16
EPS (Diluted)
-2.96-7.16
Free Cash Flow Per Share
-4.14-6.83
Effective Tax Rate
-0.04%0.00%
EBITDA
-89.92-51.44
Depreciation & Amortization
4.581.75
EBIT
-94.51-53.19
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).